Related Experiment Videos
Antidepressants in geriatric depression: what difference have they made?
1Manchester Royal Infirmary, England, UK.
International Psychogeriatrics
|January 1, 1995
Summary
Antidepressants have not significantly improved geriatric depression outcomes, with many patients experiencing relapses or persistent symptoms. Newer drug research may offer better long-term prognosis for elderly individuals with depression.
Area of Science:
- Geriatric psychiatry
- Pharmacological treatments
- Clinical depression research
Background:
- Geriatric depression presents unique challenges in treatment and prognosis.
- Understanding the long-term impact of antidepressants on elderly patients is crucial.
Purpose of the Study:
- To review evidence on antidepressant efficacy in geriatric depression prognosis.
- To examine treatment outcomes across acute, continuation, and maintenance phases.
Main Methods:
- Review of naturalistic studies post-electroconvulsive therapy introduction.
- Analysis of data on relapse rates and symptom persistence.
- Discussion of methodological challenges in geriatric depression research.
Main Results:
- Approximately 25% of elderly patients with major depression achieve symptom remission.
- About 33% experience relapses with subsequent recovery.
- 10% have severe, intractable depressive symptoms.
- Outcomes show little change since tricyclic antidepressant availability.
Conclusions:
- Current antidepressant use has limited impact on geriatric depression prognosis.
- Further research into drug prophylaxis and newer antidepressants is warranted.
- Addressing methodological issues is key for advancing treatment effectiveness.